MYRIAD GENETICS INC

Investor insights: Myriad Genetics’ chief commercial officer buys more shares via RSUs, signaling insider confidence amid volatility and a potential upside once key milestones hit.

Insightful analysis of Myriad Genetics’ new EVP’s RSU grant, revealing how insider confidence could shift volatility into steady oncology‑diagnostics growth.